Reuters
March 8 (Reuters) - Cell Therapeutics Inc (CTIC.O) said US health regulators approved the facility to manufacture its experimental cancer drug currently under review, sending its shares up 14 percent before the bell. The company said the US Food and ...
Cell Therapeutics Passes Factory TestSeattle Post Intelligencer
Cell Therapeutics says FDA clears manufacturing site for potential cancer drugCanadianBusiness.com
FDA Approves NerPharMa to Manufacture Cell Therapeutics' Drug PixantronePR Newswire (press release)
all 24 news articles »
